Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Gymnastics team wins gold
Was rushed to hospital
Wife killed a pedestrian?
Diagnosed with brain cancer
Strips news article headlines
MD bus crash: Several hurt
NFL ‘overdoing it a little bit'
Reportedly living together
Open up about rumored affair
Crackdown on illegal migrants
Russia withdraws fleet
Coast Guard rescues 12
Cop punched man 13 times?
Bridge closed due to protest
Lands on Forbes 400 list
Discounting child tickets
Texas border wall OK’d
Breast cancer awareness
To testify in welfare fraud suit
Ormond sues Weinstein
Shakur murder suspect trial
Falcons place Ali on IR
'The Buccaneers' trailer
35th birthday celebration
Jamal Adams apologizes
RU limits abortion drugs
Shares get rare downgrade
Tony Awards 2024 date set
Building collapse kills 3
Crane topples, 1 dead
‘Never take life for granted'
Interim NC House leader
Winning numbers drawn
7.5M chickens culled in SA
Amphibian extinction crisis
Announces bid for speaker
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
296,000 results
Opinion
11hOpinion
Why is Medicare rationing Alzheimer's drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer's disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
朝日新聞社5d
Alzheimer’s drug Leqembi has full FDA approval
WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for ...
WISH-TV
7d
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...
7don MSN
Health Headlines: FDA approves Alzheimer treatment
CLEVELAND, Ohio (Ivanhoe Newswire) – More than six million Americans are living with Alzheimer’s disease, it slowly steals ...
The Courier-Journal14d
Delaying Alzheimer's: Norton begins administering new drug to slow dementia progression
Every two weeks, Pam Jeffries settles into an armchair and waits for an infusion of a groundbreaking treatment for her memory loss. The new drug, which was approved by the FDA earlier this year ...
Morningstar7d
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition ...
GEN
1d
Obesity, Alzheimer’s Drugs to Drive Sales as Patent Cliff Concerns Ebb
Morningstar analyst Karen Andersen, CFA, discusses a recent report by her firm about the challenges faced by biopharma with ...
Salon21d
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
The Register-Herald
3h
Treatment hope for Alzheimer's disease
Currently there is no cure for Alzheimer's disease, a progressive neurological disease that slowly robs a person of their memory and personality and interferes with relationships. However, new drugs m ...
Journal Record
1d
FDA proposes new regulation of lab tests
The Food and Drug Administration has laid out a proposal to begin regulating laboratory medical tests, a multibillion-dollar ...
News4Jax6d
First FDA approved drug to slow Alzheimer’s
More than 6 million Americans are living with Alzheimer’s disease. It slowly steals your memories and takes away your mind. There is no cure, yet, but now, a newly FDA-approved drug is helping ...
Business Wire7d
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition “ACI”, or the “Company”), a biopharmaceutical ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices